BIOPHARMA CONGRESS III

November 14, 2017

Disruption In Biopharma

The Ritz-Carlton, Washington D.C.

1150 22nd Street, NW

 

PRESENTED BY PREVISION POLICY + Friends Of Cancer RESEARCH

drug pricing. approval standards. the future fda. Patient Input.

medicare Part B & D. the new health reform. 

 

 

2017 CONFIRMED SPEAKERS

TOM DASCHLE (BIPARTISAN POLICY CENTER)

MARK MCCLELLAN (DUKE-MARGOLIS)

JOE GROGAN (OMB)

RACHEL SHERMAN (FDA)

JANET WOODCOCK (CDER)

RICHARD PAZDUR (OCE)

PETER MARKS (CBER)

WILSON BRYAN (CBER)

 

 

LEAD 2017 SPONSOR

 

BIOPHARMA CONGRESS 2017 SPONSORS 

 

agenda

view our agenda of regulators, policy makers, and drug developers

Learn More →

Register

space is limited. register now.

Find Out How →